These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29330747)

  • 1. Recent Advances in Screening for Barrett's Esophagus.
    Sami SS; Iyer PG
    Curr Treat Options Gastroenterol; 2018 Mar; 16(1):1-14. PubMed ID: 29330747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for Barrett's esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions.
    Sami SS; Ragunath K; Iyer PG
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):623-34. PubMed ID: 24887058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovations in Screening Tools for Barrett's Esophagus and Esophageal Adenocarcinoma.
    Bell MG; Iyer PG
    Curr Gastroenterol Rep; 2021 Oct; 23(12):22. PubMed ID: 34654955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barrett's esophagus: novel strategies for screening and surveillance.
    Sanghi V; Thota PN
    Ther Adv Chronic Dis; 2019; 10():2040622319837851. PubMed ID: 30937155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Barrett's esophagus.
    Zakko L; Lutzke L; Wang KK
    Minerva Med; 2017 Feb; 108(1):28-42. PubMed ID: 27792223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett's Esophagus With a Minimally Invasive Cell Sampling Device.
    Heberle CR; Omidvari AH; Ali A; Kroep S; Kong CY; Inadomi JM; Rubenstein JH; Tramontano AC; Dowling EC; Hazelton WD; Luebeck EG; Lansdorp-Vogelaar I; Hur C
    Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1397-1404.e7. PubMed ID: 28238953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Screening Tests for Barrett's Esophagus.
    Codipilly DC; Iyer PG
    Curr Gastroenterol Rep; 2019 Jul; 21(9):42. PubMed ID: 31346777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the management of Barrett's esophagus and early esophageal adenocarcinoma.
    Singh A; Chak A
    Gastroenterol Rep (Oxf); 2015 Nov; 3(4):303-15. PubMed ID: 26486568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Barrett's esophagus and esophageal adenocarcinoma.
    Shaheen NJ
    Gastroenterology; 2005 May; 128(6):1554-66. PubMed ID: 15887151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsule endoscopy for screening for short-segment Barrett's esophagus.
    Qureshi WA; Wu J; Demarco D; Abudayyeh S; Graham DY
    Am J Gastroenterol; 2008 Mar; 103(3):533-7. PubMed ID: 18047544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2017 David Sun Lecture: Screening and Surveillance of Barrett's Esophagus: Where Are We Now and What Does the Future Hold?
    Falk GW
    Am J Gastroenterol; 2019 Jan; 114(1):64-70. PubMed ID: 30361622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of medical imaging in uncomplicated and complicated Barrett's esophagus.
    De Backer AI; De Schepper AM; Pelckmans P
    Acta Gastroenterol Belg; 2000; 63(1):22-8. PubMed ID: 10907315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
    Thrift AP
    Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a risk prediction model for Barrett's esophagus in an Australian population.
    Ireland CJ; Fielder AL; Thompson SK; Laws TA; Watson DI; Esterman A
    Dis Esophagus; 2017 Nov; 30(11):1-8. PubMed ID: 28881896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
    Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
    Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance in Barrett's esophagus: a failed premise.
    Inadomi JM
    Keio J Med; 2009 Mar; 58(1):12-8. PubMed ID: 19398879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux.
    Lin OS; Schembre DB; Mergener K; Spaulding W; Lomah N; Ayub K; Brandabur JJ; Bredfeldt J; Drennan F; Gluck M; Jiranek GC; McCormick SE; Patterson D; Kozarek RA
    Gastrointest Endosc; 2007 Apr; 65(4):577-83. PubMed ID: 17324414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
    Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
    Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.